Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPAQ Chemoprevention Efficacy in Nigerian Children
NCT05979896Phase 4Unknown
- Sponsor
- Malaria Consortium
- Start
- Jul 2023
- Primary completion
- Sep 2023
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sulfadoxine, pyrimethamine, amodiaquine in malaria, sponsored by Malaria Consortium. Status: unknown.
02
Drugs
sulfadoxinepyrimethamineamodiaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT05979896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05979896.